Global Mucoadhesive Oral Film Market Research Report 2022

Oral drug delivery is the most common route of drug administration. Nevertheless, there are some important limitations that reinforce the need for developing new drug delivery systems. Mucoadhesive oral films (MOF) are promising dosage forms that adhere to the oral mucosa and deliver the drug through it, which present several advantages. These include: bypassing the hepatic first pass effect, fast onset of action, ease of transportation and handling. The use of such dosage form is beneficial for drugs that have poor oral bioavailability and also for drugs that need to be rapidly absorbed.
Due to the COVID-19 pandemic, the global Mucoadhesive Oral Film market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Mucoadhesive Oral Film market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Mucoadhesive Oral Film landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Natural Polymer accounting for % of the Mucoadhesive Oral Film global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital and Clinic segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Mucoadhesive Oral Film include Aquestive Therapeutics, BioDelivery(BDSI), Kyukyu Pharmaceutical, Tapemark, Shilpa Therapeutics, IntelGenx, CL Pharm, Adhex Pharma and DK Livkon, etc. In terms of revenue, the global 3 largest players have a % market share of Mucoadhesive Oral Film in 2021.
This report focuses on Mucoadhesive Oral Film volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Mucoadhesive Oral Film market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Mucoadhesive Oral Film Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Natural Polymer
Synthetic Polymer
Segment by Application
Hospital and Clinic
Drug Store
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Aquestive Therapeutics
BioDelivery(BDSI)
Kyukyu Pharmaceutical
Tapemark
Shilpa Therapeutics
IntelGenx
CL Pharm
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals